Precision Ocular Ltd., of Oxford, U.K., said V-Bio Ventures had joined investors in the company's series A financing, which has raised £15.5 million (US$20.3 million) in all from investors Imperial Innovations, Consort Medical plc, Neomed and Hovione Scientia Ltd., along with V-Bio.